We review controlled trials of corticosteroid effect in experimentally elicited acute nickel contact dermatitis in man, in the hope of clarifying optimal efficacy for clinical use. To maximize discrimination and objectivity, we focus on data with 1 well-characterized allergen, nickel, in studies utilizing bioengineering documentation. Higher potency corticosteroids are effective (unlike in experimental irritant contact dermatitis), but optimum schedules still require definition.Key words: allergic contact dermatitis; corticosteroids; man; colorimetry; echography; laser Doppler flowmetry; transepidermal water loss; bioengineering methods; nickel. C Munksgaard, 2000.
Accepted for publication 24 May 2000Allergic contact dermatitis (ACD) is an inflammatory disease for which topical corticosteroid therapy is widely utilized. Corticosteroids inhibit antigen-specific activation and proliferation of lymphocytes although their exact mechanism of action remains unclear (1, 2). We review studies that utilized bioengineering techniques to evaluate the efficacy of topical corticosteroid in human experimental nickel contact dermatitis, in the hope that these highly controlled experiments might provide insight into optimum therapy.Application of allergen in sensitized patients elicits a standardized allergic contact dermatitis. Bioengineering instrumentation, such as laser Doppler flowmetry (LDF), colorimetry and echography, is useful in quantifying the skin's allergic response. LDF evaluates the intensity of the inflammatory reaction (3). Colorimetry assesses the blanching effect of corticosteroids (4). Echography evaluates edema and inflammation (5).
OverviewDe Lacharriere et al. studied the effects of clobetasol propionate 0.05%, hydrocortisone 1% and an emulsion control on experimentally elicited nickel ACD in 10 nickel-allergic patients (6). ACD was elicited by 2-day (D) patch test application of 5% NiSO 4 to the upper back. 1D following removal of nickel patches, the corticosteroids were occlusively applied for 6 h, evaluation of their efficacy occurring upon corticosteroid patch removal and again 18 h later. The corticosteroids produced a significant decrease in LDF (as well as an increase in transcutaneous pressure of oxygen) when compared to involved skin. As this was an abstract only, we do not know if they could distinguish between the compounds; this abstract also did not include the mass per unit area of corticosteroid applied.Queille-Roussel et al. (7) investigated the efficacy of clobetasol propionate 0.05% cream, hydrocortisone 1% cream and a cream vehicle on ACD,elicited by a 2-D patch application of 5% NiSO 4 on the lower back of 12 nickel-sensitive volunteers. Open application of 26 mg/cm 2 of corticosteroids 2¿ daily for 4D (D 3-6) and 1¿ on the morning of D7 followed nickel patch removal. The effect of corticosteroids was evaluated on the evening of D7. Clobetasol propionate 0.05% cream significantly decreased LDF, colorimetry and visual score values, when compared with untreated skin